Henry Schein Stock Price, News & Analysis

Henry Schein (Nasdaq: HSIC) has authorized a share repurchase program worth $400 million, complementing the remaining $33 million from a previous buyback initiated in October 2019. This new program represents approximately 4.0 percent of its 140 million outstanding shares. Executive VP Steven Paladino emphasized that this decision demonstrates the company's commitment to strategic priorities and solid cash flow generation, allowing for a balanced capital allocation strategy that supports growth and acquisitions.

Henry Schein One has launched a new software module named Consistency of Care designed to integrate dental and medical patient records. This initiative responds to the increased demand from health care providers for comprehensive patient services. Developed by Exan Software, the module enhances interoperability, allowing dental schools to share patient records with medical schools. Penn Dental Medicine is the first to adopt this module. The integration aims to improve patient care, ensure accurate health records, and streamline data management, thereby enhancing overall patient outcomes and efficiency.

Henry Schein reported record Q1 financial results with total net sales of $2.9 billion, a 20.4% increase year-over-year. This surge was driven by 14.9% internal growth in local currencies, alongside contributions from acquisitions and foreign currency exchange. GAAP net income rose to $166 million ($1.16 per diluted share), up from $130.5 million ($0.91 per diluted share) in Q1 2020. The company also raised its 2021 non-GAAP EPS guidance to at least $3.70. Despite challenges from the pandemic, Henry Schein's performance reflects strong operational execution.

Henry Schein (Nasdaq: HSIC), a leading health care solutions provider, will present at the Bank of America Securities 2021 Virtual Health Care Conference on May 11, 2021, at 10:15 a.m. ET. The presentation will be accessible via live webcast on the company's website, with a replay available afterward. Henry Schein serves over 1 million customers globally, offering more than 300 solutions that enhance operational efficiency and clinical outcomes for dental and medical practitioners. In 2020, the company reported sales of $10.1 billion, demonstrating significant growth since its public debut in 1995.

Henry Schein's CEO, Stanley M. Bergman, urged the House Select Subcommittee on the Coronavirus Crisis to include primary care physicians and dentists in the national COVID-19 vaccination effort. He emphasized their importance in addressing vaccine hesitancy and their unique access across diverse communities. The letter was part of a hearing that included expert testimonies from public health leaders. Henry Schein, a Fortune 500 company, supports healthcare professionals with technology and solutions, generating $10.1 billion in sales in 2020.

Henry Schein (Nasdaq: HSIC), a leading health care solutions provider, will announce its Q1 2021 financial results on May 4, 2021, before market opening. A live webcast of the earnings conference call will be held at 10:00 a.m. Eastern Time, featuring Stanley M. Bergman and Steven Paladino. Investors can access the call via www.henryschein.com/IRwebcasts. In 2020, Henry Schein reported sales of $10.1 billion, highlighting strong growth since going public in 1995.

Henry Schein (Nasdaq: HSIC) has acquired a majority stake in Stradis Medical, enhancing its commitment to the growing ambulatory surgery market. Stradis Healthcare specializes in medical device packaging and custom procedure kits, generating approximately $39 million in sales over the past year. The deal aims to combine product offerings, improve operational efficiencies, and create new business opportunities. While the acquisition will be neutral to HSIC’s 2021 earnings per share, it is expected to be accretive thereafter. CEO Stanley Bergman highlights the strategic importance of this partnership.

Henry Schein (Nasdaq: HSIC) announced a partnership with the Black Coalition Against COVID-19 (BCAC) to support vaccine equity via the virtual town hall series, "Making It Plain." This initiative emphasizes the essential role of primary-care physicians in increasing COVID-19 vaccination accessibility, especially in minority communities. CEO Stanley M. Bergman highlighted the importance of engaging trusted healthcare providers to ensure broader vaccine distribution. The partnership aims to create additional vaccination sites across the U.S., promoting equitable access to the COVID-19 vaccine.